{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:08:22Z","timestamp":1784268502151,"version":"3.55.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Phenotypic differences in disease expression across ethnic populations may hold the key to a better understanding of the pathophysiology of Beh\u00e7et\u2019s disease (BD), which has a wide geographical distribution and marked clinical variability between East Asian, Middle Eastern, and Western countries. In contrast to the predominance of vascular involvement in regions such as Turkey, intestinal involvement is more frequently observed in East Asian patients, particularly in Japan. Genome-wide association studies in inflammatory bowel disease (IBD), which shows clinical similarity to BD, have identified NOD2 and IL23R variants as major susceptibility loci in European populations. However, the relative absence of these IBD-related variants in East Asian populations, where intestinal BD is more prevalent, suggests the presence of alternative, BD-specific mechanisms driving gut involvement in different genetic backgrounds. Herein, we argue that this diversity in BD clinical expression may also reflect underlying differences in innate immune responses, particularly involving IL-1 signaling pathways. The striking prominence of\n                    <jats:italic>MEFV<\/jats:italic>\n                    variants (approximately 20% carrier frequency) in Turkish populations where vascular BD is more common, compared with their relative scarcity in East Asia, may offer important clues as to how population-specific genetic backgrounds shape distinct inflammatory phenotypes. In this article, we discuss these immunogenetic contrasts in relation to clinical heterogeneity, with a particular focus on the IL-1 pathway regulated by MEFV, to provide a more nuanced understanding of ethnic differences in BD pathogenesis and their implications for future therapeutic strategies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1758222","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:43:38Z","timestamp":1784267018000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Towards a basis for vascular versus intestinal phenotype differences; East Meets West in Behcet\u2019s disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Kerem","family":"Abacar","sequence":"first","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital","place":["Leeds, United Kingdom"]},{"name":"Department of Internal Medicine, Division of Rheumatology, School of Medicine, Marmara University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Macleod","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital","place":["Leeds, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Alibaz-Oner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, School of Medicine, Marmara University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haner","family":"Direskeneli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, School of Medicine, Marmara University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital","place":["Leeds, United Kingdom"]},{"name":"National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust","place":["Leeds, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.208","article-title":"Behcet syndrome: a contemporary view","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02629-6","article-title":"Behcet\u2019s syndrome","volume":"403","author":"Emmi","year":"2024","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.310","article-title":"Epidemiologic features of inflammatory bowel disease in Western Blacksea region of Turkey for the last 10 years: retrospective cohort study","volume":"34","author":"Can","year":"2019","journal-title":"Korean J Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz081","article-title":"A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the songpa-kangdong district of Seoul, Korea in 1986-2015","volume":"13","author":"Park","year":"2019","journal-title":"J Crohns Colitis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00880-7","article-title":"Vascular Behcet syndrome: from pathogenesis to treatment","volume":"19","author":"Bettiol","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001996","article-title":"Characteristics of patients with behcet disease from the van province, eastern Turkey: definition of disease clusters in a tertiary referral center","volume":"29","author":"Oguz","year":"2023","journal-title":"J Clin Rheumatol"},{"key":"B8","article-title":"Characteristics of vascular involvement in Behcet\u2019s disease in Japan: a retrospective cohort study","volume":"29","author":"Ideguchi","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1097\/MD.0000000000000494","article-title":"Behcet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses","volume":"94","author":"Alibaz-Oner","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2023.89083","article-title":"Vascular involvement in behcet\u2019s disease: an evaluation of 147 cases and literature review","volume":"57","author":"Atalar","year":"2023","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i13.3801","article-title":"Gastrointestinal Behcet\u2019s disease: a review","volume":"21","author":"Skef","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13075-021-02429-7","article-title":"Cluster analysis of phenotypes of patients with Behcet\u2019s syndrome: a large cohort study from a referral center in China","volume":"23","author":"Zou","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2305712","article-title":"Behcet\u2019s syndrome","volume":"390","author":"Saadoun","year":"2024","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/rheumatology\/ker428","article-title":"Relationships of HLA-B51 or B5 genotype with Behcet\u2019s disease clinical characteristics: systematic review and meta-analyses of observational studies","volume":"51","author":"Maldini","year":"2012","journal-title":"Rheumatol (Oxford)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/BOR.0000000000000846","article-title":"The association of Behcet\u2019s syndrome with HLA-B51 as understood in 2021","volume":"34","author":"Takeno","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4238\/2014.July.2.8","article-title":"HLA-B51 subtypes in Turkish patients with Behcet\u2019s disease and their correlation with clinical manifestations","volume":"13","author":"Demirseren","year":"2014","journal-title":"Genet Mol Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Behcet\u2019s disease, the Silk Road and HLA-B51: historical and geographical perspectives","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"key":"B18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13075-020-02406-6","article-title":"Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behcet\u2019s disease in Japan","volume":"23","author":"Soejima","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2019.1649103","article-title":"The influence of HLA-B51 on clinical manifestations among Japanese patients with Behcet\u2019s disease: A nationwide survey","volume":"30","author":"Mizuki","year":"2020","journal-title":"Mod Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00535-020-01690-y","article-title":"Evidence-based diagnosis and clinical practice guidelines for intestinal Behcet\u2019s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants","volume":"55","author":"Watanabe","year":"2020","journal-title":"J Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roae022","article-title":"Significant association of HLA-A26 with uveitis and gastrointestinal involvement in patients with Behcet\u2019s disease in a multicenter study","volume":"34","author":"Nakajima","year":"2024","journal-title":"Mod Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.147","article-title":"\u2018MHC-I-opathy\u2019-unified concept for spondyloarthritis and Behcet disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103293","article-title":"Short chain fatty acids and its producing organisms: An overlooked therapy for IBD","volume":"66","author":"Deleu","year":"2021","journal-title":"EBioMedicine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3390\/nu12040944","article-title":"Nutrition, IBD and gut microbiota: A review","volume":"12","author":"Mentella","year":"2020","journal-title":"Nutrients"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.3390\/nu14194003","article-title":"Dietary patterns and gut microbiota changes in inflammatory bowel disease: current insights and future challenges","volume":"14","author":"Yan","year":"2022","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109657","article-title":"Clinical trait-specific genetic analysis in Behcet\u2019s disease identifies novel loci associated with ocular and neurological involvement","volume":"253","author":"Casares-Marfil","year":"2023","journal-title":"Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.844304","article-title":"Interleukin-1-related genes polymorphisms in Turkish patients with Behcet disease: a meta-analysis","volume":"24","author":"Zou","year":"2014","journal-title":"Mod Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.12.021","article-title":"A genome-wide association study identifies 2 susceptibility Loci for Crohn\u2019s disease in a Japanese population","volume":"144","author":"Yamazaki","year":"2013","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/srep18584","article-title":"Association of Interleukin-23 receptor gene polymorphisms with susceptibility to Crohn\u2019s disease: A meta-analysis","volume":"5","author":"Xu","year":"2015","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305193","article-title":"Genome-wide association study of Crohn\u2019s disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations","volume":"63","author":"Yang","year":"2014","journal-title":"Gut"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06339.x","article-title":"IL-10 and IL-10 receptor defects in humans","volume":"1246","author":"Glocker","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gendis.2019.10.003","article-title":"Genetics on early onset inflammatory bowel disease: An update","volume":"7","author":"Nameirakpam","year":"2020","journal-title":"Genes Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet\u2019s disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2008-11","article-title":"Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review","volume":"50","author":"Tufan","year":"2020","journal-title":"Turk J Med Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200674","article-title":"Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population","volume":"9","author":"Yilmaz","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68430-4","article-title":"Familial mediterranean fever in Arabs","volume":"367","author":"El-Shanti","year":"2006","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318277cf75","article-title":"Familial mediterranean fever in Japan","volume":"91","author":"Migita","year":"2012","journal-title":"Med (Baltimore)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1306352110","article-title":"Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease","volume":"110","author":"Kirino","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B43","article-title":"MEFV mutations are increased in Behcet\u2019s disease (BD) and are associated with vascular involvement","volume":"21","author":"Atagunduz","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/03009740600759639","article-title":"Common FMF alleles may predispose to development of Behcet\u2019s disease with increased risk for venous thrombosis","volume":"36","author":"Rabinovich","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2022.117843","article-title":"Association of MEFV mutations and vascular involvement in Behcet\u2019s disease: a study from Hatay, Turkey","volume":"60","author":"Serarslan","year":"2022","journal-title":"Reumatologia"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2011-y","article-title":"The frequency of MEFV gene mutations in Behcet\u2019s disease and their relation with clinical findings","volume":"32","author":"Yazici","year":"2012","journal-title":"Rheumatol Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2013.08.026","article-title":"Common MEFV gene mutations in Turkish patients with Behcet\u2019s disease","volume":"530","author":"Tasliyurt","year":"2013","journal-title":"Gene"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109630","article-title":"Behcet disease, familial Mediterranean fever and MEFV variations: More than just an association","volume":"251","author":"Seyahi","year":"2023","journal-title":"Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.3390\/jcm12093131","article-title":"Possible association of mutations in the MEFV gene with the intestinal phenotype of Behcet\u2019s disease and refractoriness to treatment","volume":"12","author":"Furuta","year":"2023","journal-title":"J Clin Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0439-7","article-title":"Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations","volume":"16","author":"Kishida","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02733","article-title":"FMF is associated with a wide spectrum of MHC class I- and allied SpA disorders but not with classical MHC class II-associated autoimmune disease: insights from a large cohort study","volume":"10","author":"Watad","year":"2019","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2013.6","article-title":"T helper 17 polarization in familial Mediterranean fever","volume":"14","author":"Ovadia","year":"2013","journal-title":"Genes Immun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.06.012","article-title":"Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1beta, IL-1alpha and Th17-associated cytokines and decrease of Th1 and Th2 cytokines","volume":"69","author":"Ibrahim","year":"2014","journal-title":"Cytokine"},{"key":"B54","article-title":"Polyarteritis nodosa: lessons from 25 years of experience","author":"Sonmez","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00763","article-title":"Association of vasculitis and familial mediterranean fever","volume":"10","author":"Abbara","year":"2019","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead153","article-title":"Increased risk for stroke in patients with familial Mediterranean fever: results from a large population-based study","volume":"62","author":"Ben-Shabat","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad084","article-title":"NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis","volume":"119","author":"Potere","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1172\/JCI79329","article-title":"Caspase-1-mediated pathway promotes generation of thromboinflammatory microparticles","volume":"125","author":"Rothmeier","year":"2015","journal-title":"J Clin Invest"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.160.2.618","article-title":"Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells","volume":"160","author":"Bevilacqua","year":"1984","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.10.3460","article-title":"Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity","volume":"83","author":"Nawroth","year":"1986","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B61","doi-asserted-by":"publisher","first-page":"eaar6676","DOI":"10.1126\/sciimmunol.aar6676","article-title":"Noncanonical inflammasome signaling elicits gasdermin D-dependent neutrophil extracellular traps","volume":"3","author":"Chen","year":"2018","journal-title":"Sci Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.immuni.2019.11.005","article-title":"Bacterial endotoxin activates the coagulation cascade through gasdermin D-dependent phosphatidylserine exposure","volume":"51","author":"Yang","year":"2019","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00253","article-title":"Familial mediterranean fever: recent developments in pathogenesis and new recommendations for management","volume":"8","author":"Ozen","year":"2017","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg232R","article-title":"Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet\u2019s disease","volume":"42","author":"Karasneh","year":"2003","journal-title":"Rheumatol (Oxford)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)80068-p","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90229","article-title":"Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling","volume":"127","author":"Quiros","year":"2017","journal-title":"J Clin Invest"},{"key":"B69","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1053\/j.gastro.2017.11.276","article-title":"Pyrin inflammasome regulates tight junction integrity to restrict colitis and tumorigenesis","volume":"154","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.03.003","article-title":"The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis","volume":"32","author":"Zaki","year":"2010","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402098","article-title":"The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis","volume":"194","author":"Williams","year":"2015","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585134","article-title":"Interleukin (IL)-12 and IL-18 synergize to promote MAIT cell IL-17A and IL-17F production independently of IL-23 signaling","volume":"11","author":"Cole","year":"2020","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1082-x","article-title":"Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2","volume":"568","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1126\/science.1249288","article-title":"Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis","volume":"343","author":"Mortha","year":"2014","journal-title":"Science"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.13","article-title":"Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3(+) Treg cell function in the intestine","volume":"8","author":"Harrison","year":"2015","journal-title":"Mucosal Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae585","article-title":"Infliximab versus interferon-alpha in the treatment of Behcet\u2019s Syndrome: Clinical data from the BIO-BEH&Ccedil;ET\u2019S randomised controlled trial","volume":"64","author":"Moots","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1124628","article-title":"IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis","volume":"14","author":"Deng","year":"2023","journal-title":"Front Pharmacol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217108","article-title":"Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behcet\u2019s phenotype: a multicentre study","volume":"79","author":"Fagni","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201876","article-title":"Mechanism of IL-1beta modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation","volume":"190","author":"Al-Sadi","year":"2013","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217307","article-title":"A pilot study of tofacitinib for refractory Behcet\u2019s syndrome","volume":"79","author":"Liu","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221124014","article-title":"Tofacitinib as an alternative therapy for refractory intestinal Behcet\u2019s syndrome","volume":"14","author":"Zou","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.7","article-title":"Back to the future: oral targeted therapy for RA and other autoimmune diseases","volume":"9","author":"O\u2019Shea","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300354","article-title":"Infliximab versus cyclophosphamide for severe Behcet\u2019s syndrome","volume":"3","author":"Saadoun","year":"2024","journal-title":"NEJM Evid"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2022.63.2.148","article-title":"Efficacy and safety of anti-tumor necrosis factor-alpha agents for patients with intestinal Behcet\u2019s disease: A systematic review and meta-analysis","volume":"63","author":"Zhang","year":"2022","journal-title":"Yonsei Med J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1758222\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:43:40Z","timestamp":1784267020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1758222\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":85,"alternative-id":["10.3389\/fimmu.2026.1758222"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1758222","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"1758222"}}